• Operational volume growth: Inpatient discharges rose nearly 28% and deliveries grew 26%, with mature hospitals contributing 74%–75% of overall business and 40% of growth, while newer hospitals drove 27%.
• PAT growth reconciliation: The lag in PAT growth (16% YoY) relative to EBITDA growth (30%) was driven by initial costs from launching four hospitals in three months, an earnings gap expected to close within five to six months.
• Geographic expansion strategy: The company is expanding into western Indian markets, with a new pediatric super-specialty hospital in Malad, Mumbai targeted for Q1 FY28, alongside upcoming projects in Pune, Indore, and Gurugram.
• ARPOB growth drivers: Average revenue per operating bed is projected to continue climbing, supported by insurance price revisions and an increased mix of complex quaternary procedures such as pediatric organ transplants and high-risk deliveries.
• Occupancy and payer mix: Management is targeting an ideal 51%–52% occupancy mix across mature hospitals, while the current payer mix of 52% insurance and 48% cash is expected to skew further toward insurance as newer facilities mature.